What's new

Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 46, Status: Authorised

Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 46, Status: Authorised

May 12, 2025 - 13:59
 0
Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 46, Status: Authorised
Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 46, Status: Authorised
Read More

Tags:

Previous Article

Experts may agree with RFK Jr. on fewer Covid shots

Next Article

UK windfall tax can fund switch to green jobs for North Sea oil workers – report

Related Posts

Human medicines European public assessment report (EPAR): HyQvia, human normal immunoglobulin, Date of authorisation: 16/05/2013, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 5, 2025  0

PRIME: priority medicines

PRIME: priority medicines

May 6, 2025  0

UPD registration guide for UI and API users

May 6, 2025  0